Reierson, adding that, Ozempic also slows the rate of food passing through the stomach and GI tract, resulting in less hunger and early satiety. Needless to say, this hunger-reducing effect of the drug can result in significant weight loss
Twenty-nine patients (14 men, 15 women, mean age 56.0 13.3 years) finished the study protocol
The study also indicated that GLP-1 RA treatment was associated with a moderately increased risk of gallstones (RR: 1.27, 95% CI 1.101.47), cholecystitis (RR: 1.36, 95% CI 1.141.62), and overall gallbladder disease risk (RR: 1.55, 95% CI 1.082.22) compared to placebo
It also advises confirming the clinic runs baseline labs, maintains follow-up monitoring, and partners with licensed 503A compounding pharmacies for compounded options
Some states have added GLP-1 coverage for obesity while others continue to exclude weight loss medications from their formularies entirely